FATE
Fate Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD2.66
+0.24 (+9.92%)
Rating:C
Company Profile
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$2.42
Prev. Close
$2.42
Day Low
$2.38
Day High
$2.69
52W Low
$0.91
52W High
$2.88
Market Cap
$0.31B
Volume
3.42M